Aradigm Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.11 |
Market Cap |
$19.76 M |
Shares Outstanding |
15.2 M |
Public Float |
9.56 M |
Address |
3929 Point Eden Way Hayward California 94545 United States |
Employees | - |
Website | http://www.aradigm.com |
Updated | 09/14/2018 |
Aradigm Corp. operates as a pharmaceutical company, which focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. Its technologies include diabetes and pain management, AERx essence devices. The company was founded in 1991 and is headquartered in Hayward, CA. |